MetaCap

Soligenix (SNGX) vs Universe Pharmaceuticals (UPC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Universe Pharmaceuticals is the larger company by market cap ($5.4 million vs $5.1 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SNGX-37.74%UPC-74.91%
+10%-34%-79%
Oct 7, 20261 yearNov 20, 2026
SNGX-39.47%UPC-73.98%
+9%-35%-78%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SNGX versus UPC key metrics
MetricSNGXUPC
Share price$0.2201$1.08
Market cap$5.14M$5.43M
1-day change-8.29%-20.59%
YTD return—-71.65%
1-year return—-68.24%
5-year return—-99.99%
EPS (TTM)$-0.21$-1.38
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$17.86B
Revenue growth (YoY)—-22.44%
Net income (latest FY)$-11.08M$-3.67B
Gross margin—35.28%
Operating margin—-16.33%
Net margin—-20.56%
52-week high$1.70$17.96
52-week low$0.21$1.05
Distance from 52-week high-87.05%-93.99%
Analyst consensusnone—
Avg. price target upside+526.99%—
Average volume198.15K176.76K
Shares outstanding23.37M5.01M
Employees13216
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Soligenix

SNGX stock →

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions.

Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees

About Universe Pharmaceuticals

UPC stock →

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.

Health Care · Biotechnology: Pharmaceutical Preparations · 216 employees

SNGX vs UPC FAQ

Which is bigger, Soligenix or Universe Pharmaceuticals?

Universe Pharmaceuticals (UPC) is larger, with a market capitalization of $5.43M compared with $5.14M for Soligenix (SNGX).

Are Soligenix and Universe Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons